|
HS Code |
731480 |
| Chemicalname | 3-Bromo-1-methyl-6-oxo-1,6-dihydropyridine |
| Molecularformula | C6H6BrNO |
| Molecularweight | 188.02 g/mol |
| Casnumber | 1190310-28-3 |
| Appearance | Off-white to yellow solid |
| Solubility | Slightly soluble in water, soluble in organic solvents |
| Purity | Typically ≥ 97% |
| Smiles | CN1C=CC(Br)=CC1=O |
| Inchi | InChI=1S/C6H6BrNO/c1-8-3-2-4(7)5-6(8)9/h2-3H,1H3 |
| Storagetemperature | Store at 2-8°C, protected from light |
| Hazardstatement | May cause irritation to eyes, respiratory system and skin |
As an accredited 3-Bromo-1-methyl-6-oxo-1,6-dihydropyridine factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | The chemical is packaged in a 25g amber glass bottle with a secure screw cap, labeled with product details and safety information. |
| Container Loading (20′ FCL) | Container Loading (20′ FCL) for 3-Bromo-1-methyl-6-oxo-1,6-dihydropyridine ensures secure, moisture-free packaging and efficient bulk shipment. |
| Shipping | **Shipping Description:** 3-Bromo-1-methyl-6-oxo-1,6-dihydropyridine is shipped in tightly sealed containers, protected from moisture and direct sunlight. Handle in accordance with standard chemical transport regulations. Avoid extreme temperatures. Ensure compliant labeling and documentation. Shipping may be restricted based on classification and destination, and should only be handled by authorized personnel with proper safety measures. |
| Storage | **3-Bromo-1-methyl-6-oxo-1,6-dihydropyridine** should be stored in a tightly sealed container, in a cool, dry, and well-ventilated area, away from heat, moisture, and incompatible substances such as strong oxidizers. Protect the chemical from direct sunlight and ignition sources. Store at room temperature, and ensure proper labeling. Avoid prolonged exposure to air to prevent decomposition. |
| Shelf Life | Shelf life: Store 3-Bromo-1-methyl-6-oxo-1,6-dihydropyridine in a cool, dry place; stable for at least two years. |
|
Purity 99%: 3-Bromo-1-methyl-6-oxo-1,6-dihydropyridine with purity 99% is used in pharmaceutical intermediate synthesis, where it ensures high yield and reduced by-product formation. Melting Point 145°C: 3-Bromo-1-methyl-6-oxo-1,6-dihydropyridine at melting point 145°C is used in solid-phase organic synthesis, where it provides reliable thermal stability during processing. Molecular Weight 216.04 g/mol: 3-Bromo-1-methyl-6-oxo-1,6-dihydropyridine at molecular weight 216.04 g/mol is used in medicinal chemistry research, where it enables precise stoichiometric calculations for compound development. Particle Size <50 μm: 3-Bromo-1-methyl-6-oxo-1,6-dihydropyridine with particle size less than 50 μm is used in fine chemical formulation, where it improves dissolution rates and homogeneity in solution. Stability Temperature 80°C: 3-Bromo-1-methyl-6-oxo-1,6-dihydropyridine stable at 80°C is used in high-temperature reaction protocols, where it maintains compound integrity under extended heating conditions. |
Competitive 3-Bromo-1-methyl-6-oxo-1,6-dihydropyridine prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please contact us at +8615371019725 or mail to sales7@bouling-chem.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: sales7@bouling-chem.com
Flexible payment, competitive price, premium service - Inquire now!
Working directly with chemists and engineers in the field, it’s impossible to ignore how certain intermediates just seem to solve more problems than others. Among the steady expansion of nitrogen-containing heterocycles, 3-Bromo-1-methyl-6-oxo-1,6-dihydropyridine has gradually carved out its place as a reliable and sought-after tool, especially for those of us in the business of fine chemicals. What sets this compound apart becomes clear once you get hands-on with it, both as a bench chemist and as someone responsible for large-scale production where every detail matters.
Manufacturing compounds that bridge the basic research bench and industrial use demands clarity on what unique value a material like this brings. This one stands out for its bromo group at the 3-position and its ketone at the 6-position in a methylated pyridine ring. That combination opens up reactivity pathways that more basic dihydropyridines can’t match. In process chemistry, we watch how a material handles—solubility, purification, thermal stability, and compatibility with other reagents. Over the years, this compound has shown a consistent profile: it dissolves well in most organic solvents, doesn’t decompose too quickly, and works with standard purification techniques—no endless headaches trying to track down byproducts or side reactions.
When we move from laboratory to production scale, little quirks become major. Some pyridine derivatives generate odors or harsh volatiles, especially under heat. Our direct handling experience confirms that 3-Bromo-1-methyl-6-oxo-1,6-dihydropyridine gives minimal issues in this respect. Our workers don’t have to struggle with ventilation problems or frequent exposure complaints—key for maintaining both a safe workplace and good morale on the production floor.
The finer points of product quality become especially relevant for API and agrochemical projects. I’ve seen teams lose weeks because of batch-to-batch inconsistency with similar compounds sourced elsewhere. Our facility prioritizes exacting process control, employing HPLC and NMR as routine quality checkpoints with every lot we produce. For this intermediate, our batches have held to a GC purity well above 98 percent, typically reaching 99 percent. That consistency has caught the attention of research partners who have shared that regular supply interruptions, or swings in impurity profile, sabotaged scale-up elsewhere. Even when switching up reaction partners—whether halogen-metal exchange, palladium-catalyzed cross-coupling, or simple nucleophilic substitutions—the results stay repeatable. That saves time and budget at every step downstream.
Most inquiries for 3-Bromo-1-methyl-6-oxo-1,6-dihydropyridine come from the pharmaceutical sector. Customers are building advanced intermediates for a variety of categories—antivirals, oncology agents, central nervous system actives, and more. Some of this demand comes from its versatility in Suzuki and Buchwald-Hartwig coupling reactions, where that 3-bromo substituent enables highly selective aryl or amine attachments. Others value the 6-oxo group for its ability to direct regioselective modifications on the ring. Agricultural chemistry labs use the same reactivity principles to create next-generation herbicide and pesticide scaffolds, often looking for enhanced safety or metabolic stability through smart ring substitutions.
We get detailed technical feedback every quarter. Researchers have pointed out that, compared to unsubstituted or 3-chloro analogues, yields often run higher and final products contain fewer minor byproducts. Sometimes what matters most isn’t what is present, but what isn’t; the clean reaction profiles mean less stress through regulatory filings. Process developers come back with new plans, often taking for granted that supply will remain stable. We understand what’s at stake with clinical and commercial launches on the line, and respond by holding extra inventory and investing ahead into raw material security. That’s only possible when you control the manufacturing yourself.
One thing that sets our approach apart is the level of process transparency we provide. The synthesis route for this compound involves selective bromination under controlled conditions, followed by methylation and ring oxidation. During development, our technical team tracked exotherms and byproduct formation, tinkering with stoichiometry and solvent loadings to reduce wandering into untracked impurity territory. Through each campaign, we’re onsite monitoring endpoints, sampling intermediates, and listening to operators about handling pain points. This on-the-ground knowledge allows us to document residual risk, recommend optimum storage conditions, and support rapid troubleshooting if a partner lab encounters unexpected results.
From experience, it’s clear that safety doesn’t end at hazard statements on a shipping paper. We select our solvents and cleaning procedures based on operator feedback as much as regulatory checkboxes. Avoiding chlorinated solvents wherever possible and prioritizing closed-system transfers helps keep both product integrity and staff exposure profiles in check. Material handling training and layered containment are table stakes. Whenever someone asks about shelf stability or compatibility with standard glassware and plastics, we can answer from direct handling experience—not just technical notes downloaded from a database.
Early in my manufacturing career, I worked through the scale-up of multiple pyridine and dihydropyridine derivatives. Each one brings its own set of lessons. Simple methyl-substituted versions often lack the site selectivity or reactivity profile needed for more complex syntheses. Chloro and fluoro variants can work for some cross-coupling approaches, but tend to require harsher activation or give more legacy waste. What I saw with 3-Bromo-1-methyl-6-oxo-1,6-dihydropyridine is that entry into broader palladium-catalyzed chemistry often runs cleaner, especially for arylation. Bromine, in this context, carries more predictability in sp2 carbon chemistry—less recourse to exotic conditions, more predictable conversion. The methyl group at the 1-position also subtly tunes electron density on the ring, which can matter when seeking specific regioselectivity in downstream modifications or seeking to avoid over-activation that's sometimes a headache with the non-methylated variants.
It’s also critical to mention physical properties that matter to people handling kilograms or larger. In comparison with high-melting analogues or those prone to hydrolysis, this one commonly presents as a well-behaved crystalline solid. That’s not just a spreadsheet entry—less clumping, improved weighing accuracy, less waste. Moisture uptake is minimal; end users rarely report issues with caking or flow. Package shelf life remains reliable across standard cycles of handling. Those are details we track, because every return shipment is direct cost and lost goodwill.
Being on the factory side gives a front-row seat to recurring themes our customers care about. Nobody wants to fight through bureaucratic hurdles or run into “out of stock” signs just as a pilot project is ready to launch. We keep one eye on raw materials and one eye on regulatory shifts affecting intermediates. The goal is steady availability and documented compliance, not just a technical win. Multiple customers have noted that their procurement teams feel better sourcing directly from manufacturers rather than from shadowy resellers—traceability matters more as projects mature toward clinical or field deployment. Internal batch records link back not only to our own QC data, but also to verifiable supply chain documentation. That control is hard to fake, and it allows us to support our partners' own EHS and quality audits with confidence.
Logistical flexibility can be just as important as the chemical itself. We’ve invested in packaging solutions that dodge issues—no one-size-fits-all drums or bags. Requests for specific liners, container types, tamper-evident closures, and custom batch sizing are met because we see firsthand how much heartbreak those details can prevent down the line. More than one firm has circled back and asked us to hold reserved material or pre-stage shipments for ongoing process campaigns. Our production planning incorporates such long-term arrangements by default, not as an afterthought. Doing the actual manufacturing means we decide how much safety stock sits in reserve. Value comes from knowing that, not simply finding a low price from a middleman with no skin in the game.
Audit trails run deep in this business. Internal procedures detail each processing step, and all raw materials trace to source. We can generate history for every lot released; this assurance flows into our documentation for downstream customer filings. Routine third-party analytical confirmation, not just in-house checks, underpins our COA standards. Regulatory inspection is part of our normal cadence; we keep data packages ready and welcome partners to onsite or remote audits. Our IT staff built traceability modules specifically for fine chemicals, so it’s routine to answer customer audits with direct data, Gantt charts, and risk assessment summaries. That level of transparency feeds confidence and supports robust GMP or ISO documentation for finished product filings.
Shipping regulations around this compound generally allow standard ground and air options, but our experience emphasizes that double-checking UN ratings and container labels matters. Some destinations apply bespoke import or testing rules. Our shipping team regularly updates SOPs in consultation with specialized forwarders. Each consignment moves with full batch history and MSDS, but also real-world feedback from handlers and previous importers. Receiving teams regularly report that our labeling simplifies reconciliation—batch, expiry, and lot data are matched to both original production dates and retest intervals.
We’ve fielded requests for custom particle sizing to improve downstream wetting or flow. Some partners need support troubleshooting scale-up in their own plants—here, our technical staff provides guidance based on what’s worked (and not worked) in our own reactors. We do our own chemical compatibility checks, answering questions on storage with specific data, not just boilerplate advice. If a new formulation needs reassurance on stability, our teams run aging and stress testing, drawing from what happens in our own storage vaults. Our best partnerships grow from this two-way communication, not just a one-off sale.
The truth is, even the best technical literature can’t replace lived experience. Each client brings unique targets—gram scale for research, multi-ton shipments for established products. As a manufacturer, we value the repeat visits, the technical deep-dives, and the feedback when issues arise, because those shape our future improvements. Whether a research chemist calls about reactivity under microwave conditions or a production manager gives us throughput pain points, we turn that into changes that keep this intermediate competitive. That attitude sets manufacturing apart from trading. It’s not theory; it’s practice.
Shifting from laboratory to full-scale production reveals hidden challenges. Solvent recovery, waste management, and batch scheduling complications rarely show up on a small scale. Our batch records take all this into account. Full-scale campaigns involve real-time process controls, with automated dosing and in-line analytics to minimize operator risk and track critical quality attributes. Deviations are flagged, and root causes are investigated immediately, not after-the-fact. Process data feedback gets folded into subsequent production runs, closing the loop between quality, yield, and operator safety.
Downstream, we communicate openly about handling limitations or sensitivities that might not surface in technical datasheets. End-users in pharma and agrochemical R&D have found that knowing the true thermal and hydrolytic stability range of a compound saves time preparing for regulatory submission or process transfer. Our packaging specs arise from these lived operational challenges rather than spreadsheet logic. More than once, feedback from our warehouses led to real tweaks—thicker liners here, improved desiccants there—not cosmetic changes, but actual improvements in delivered material quality.
One persistent challenge with heterocyclic intermediates is impurity formation during scale-up. Reactions that seem clean on paper can go sideways without close monitoring. Our facility runs full trace impurity testing on large batches, because we know how even low-level contaminants can derail a formulation or set back a drug development program. Over time, we refined our synthetic steps to minimize isomeric and halogenated byproducts, sometimes altering crystallization conditions or switching suppliers for key reagents.
We share typical impurity profiles with clients upfront, not just compliance values. If a process requires further reduction of specific impurities, we advise on additional purification runs—sometimes even batch splits for custom clean-up. Clients have returned with improved yields and easier regulatory review cycles, mainly because there are no surprises buried in the output. Our experience with chromatographic and crystallization processes gives us a broad toolkit for tackling off-spec material—something traders rarely want to invest in.
Our work making 3-Bromo-1-methyl-6-oxo-1,6-dihydropyridine brings a sense of accomplishment rooted in technical progress and customer trust. This business isn’t just about shipments fulfilled, but relationships built on the ground, from pilot runs to production campaigns that feed directly into breakthrough medicines and agricultural solutions. Over the years we’ve learned that success in chemical manufacturing rests on much more than cost. Precision, transparency, and accountability define real value for users counting on a consistent supply. Each improvement in yield, safety, packaging, or purity means faster progress for our customers’ innovations.
Being manufacturers, we stand behind our business with real-world results, continuous process support, and product quality that reflects years of hands-on development. For those who need more than a spec sheet—who depend on a reliable partner through the twists and turns of scale-up, regulation, and market uncertainty—the difference is clear. We’re here for the tough questions, the repeat tweaks, and the ongoing dialogue that turns a chemical into a critical tool for future breakthroughs.